摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,4,5-trichlorothiophenol | 57730-96-8

中文名称
——
中文别名
——
英文名称
3,4,5-trichlorothiophenol
英文别名
3,4,5-trichlorobenzenethiol
3,4,5-trichlorothiophenol化学式
CAS
57730-96-8
化学式
C6H3Cl3S
mdl
——
分子量
213.515
InChiKey
VHUYFTLLFNDZPS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    1
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    3,4,5-trichlorothiophenolcopper(l) iodide 、 sodium hydride 作用下, 以 N,N-二甲基甲酰胺乙腈 、 mineral oil 为溶剂, 反应 24.91h, 生成
    参考文献:
    名称:
    [EN] ALPHA-D-GALACTOSIDE INHIBITORS OF GALECTINS
    [FR] INHIBITEURS ALPHA-D-GALACTOSIDE DE GALECTINES
    摘要:
    本发明涉及一般式(1)的化合物。其中吡喃糖环为α-D-半乳糖,A选自。该式(1)化合物适用于治疗与在哺乳动物,如人类中的一个配体结合相关的疾病的方法。此外,本发明涉及用于治疗与在哺乳动物,如人类中的一个配体结合相关的疾病的方法的化合物。
    公开号:
    WO2016120403A1
  • 作为产物:
    描述:
    3,4,5-三氯苯胺盐酸乙醇 、 potassium hydroxide 、 sodium nitrite 作用下, 以 为溶剂, 反应 4.0h, 生成 3,4,5-trichlorothiophenol
    参考文献:
    名称:
    [EN] ALPHA-D-GALACTOSIDE INHIBITORS OF GALECTINS
    [FR] INHIBITEURS ALPHA-D-GALACTOSIDE DE GALECTINES
    摘要:
    本发明涉及一种通式(1)的化合物。通式(1)的化合物适用于治疗与在哺乳动物(如人类)中的一个半乳凝集素(例如半乳凝集素-1)与配体结合有关的疾病的方法。此外,本发明涉及一种治疗与在哺乳动物(如人类)中的一个半乳凝集素(例如半乳凝集素-1)与配体结合有关的疾病的方法。
    公开号:
    WO2018011093A1
点击查看最新优质反应信息

文献信息

  • Phenylpyridazine compounds and medicines containing the same
    申请人:Kowa Co., Ltd.
    公开号:US06664256B1
    公开(公告)日:2003-12-16
    Phenylpyridazine compounds represented by the following formula (I): are provided, wherein R1, R2, R3, R4, and n are as defined herein having excellent inhibitory activity against interleukin-1&bgr; production, and useful in the treatment of prevention of diseases caused by stimulation of interleukin-1&bgr; production, such as immune system diseases, inflammatory diseases, and ischemic diseases.
    以下公式(I)所代表的苯基吡啶化合物提供,其中R1、R2、R3、R4和n如本文所定义,具有出色的抑制性活性,可用于治疗或预防由白细胞介素-1β产生刺激引起的疾病,如免疫系统疾病、炎症性疾病和缺血性疾病。
  • [EN] TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES<br/>[FR] COMPOSÉS DE TÉTRAZOLINONE ET LEUR UTILISATION EN TANT QUE PESTICIDES
    申请人:SUMITOMO CHEMICAL CO
    公开号:WO2013162072A1
    公开(公告)日:2013-10-31
    The present invention provides a compound having an excellent efficacy for controlling pests. A tetrazolinone compound of a formula (1): [wherein R1 represents an C6-C16 aryl group, an C1-C12 alkyl group, or a C3-C12 cycloalkyl group, etc., which each optionally be substituted; R2, R3, R4 and R5 represent independently of each other a hydrogen atom, a halogen atom or an C1-C3 alkyl group, etc.; R6 represents an C1-C6 alkyl group, a C3-C6 cycloalkyl group, a halogen atom, a C1-C6 haloalkyl group, an C2-C6 alkenyl group, an C1-C6 alkoxy group, or a C1-C6 haloalkoxy group, etc.; R7, R8 and R9 represent independently of each other a hydrogen atom, a halogen atom, or an C1-C4 alkyl group, etc.; X represents an oxygen atom or a sulfur atom; and R10 represents an C1-C6 alkyl group, etc.] shows an excellent controlling efficacy on pests.
    本发明提供了一种具有优异杀虫效果的化合物。公式(1)的四唑酮化合物:[其中R1代表C6-C16芳基、C1-C12烷基或C3-C12环烷基等,每个都可以选择性地被取代;R2、R3、R4和R5分别独立地代表氢原子、卤素原子或C1-C3烷基等;R6代表C1-C6烷基、C3-C6环烷基、卤素原子、C1-C6卤代烷基、C2-C6烯基、C1-C6烷氧基或C1-C6卤代烷氧基等;R7、R8和R9分别独立地代表氢原子、卤素原子或C1-C4烷基等;X代表氧原子或原子;R10代表C1-C6烷基等]在杀虫方面表现出优异的控制效果。
  • [EN] TETRAZOLINONE COMPOUNDS AND ITS USE<br/>[FR] COMPOSÉS DE TÉTRAZOLINONE ET LEUR UTILISATION
    申请人:SUMITOMO CHEMICAL CO
    公开号:WO2013162077A1
    公开(公告)日:2013-10-31
    The present invention provides a compound having an excellent efficacy for controlling pests. A tetrazolinone compound of a formula (1): [wherein, R1 represents an C6-C16 aryl group, an C1-C12 alkyl group, a C3-C12 cycloalkyl group or an adamantyl group, etc., which each optionally be substituted; R2 represents a hydrogen atom, an C1-C12 alkyl group, or a halogen atom, etc.; R4 and R5 represent independently of each other a hydrogen atom or an C1-C3 alkyl group, etc.; R6, R7, R8 and R9 represent independently of each other a hydrogen atom, a halogen atom, an C1-C12 alkyl group, a C1-C12 haloalkyl group, an C2-C12 alkenyl group, a C3-C12 cycloalkyl group, an C1-C12 alkoxy group or a C1-C12 haloalkoxy group, etc.; X and Y represent independently of each other a sulfur atom or an oxygen atom; Q represents an oxygen atom or a sulfur atom; and R10 represents an C1-C6 alkyl group, etc.] shows an excellent controlling efficacy on pests.
    本发明提供了一种具有优异杀虫效果的化合物。式(1)中的四氮杂酮化合物:[其中,R1代表一个C6-C16芳基,一个C1-C12烷基,一个C3-C12环烷基或一个金刚烷基等,每个都可以选择性地被取代;R2代表一个氢原子,一个C1-C12烷基或一个卤素原子等;R4和R5分别独立地代表一个氢原子或一个C1-C3烷基等;R6、R7、R8和R9分别独立地代表一个氢原子,一个卤素原子,一个C1-C12烷基,一个C1-C12卤代烷基,一个C2-C12烯基,一个C3-C12环烷基,一个C1-C12烷氧基或一个C1-C12卤代烷氧基等;X和Y分别独立地代表一个原子或一个氧原子;Q代表一个氧原子或一个原子;R10代表一个C1-C6烷基等]对害虫有极佳的控制效果。
  • [EN] 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS<br/>[FR] COMPOSES 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE POUR LE TRAITEMENT DE LA TUBERCULOSE
    申请人:OTSUKA PHARMA CO LTD
    公开号:WO2005042542A1
    公开(公告)日:2005-05-12
    The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: (1)in the above formula (1), R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R1 and -(CH2)nR2 may form a spiro ring represented by the formula (30) below, together with the adjacent carbon atom (in the formula below, RRR represents a piperidyl group which may have substituents on the piperidine ring), (30)and R2 represents a benzothiazolyloxy group, quinolyloxy group, pyridyloxy group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria.
    本发明提供了一种由以下一般式表示的2,3-二氢-6-硝基咪唑[2,1-b]噁唑化合物:(1)在上述式(1)中,R1代表氢原子或C1-C6烷基,n代表0至6的整数,R1和-(CH2)nR2可以与下面的式(30)一起形成一个螺环,与相邻的碳原子一起(在下面的式中,RRR代表可能在哌啶环上具有取代基的哌啶基),(30)和R2代表苯并噻唑氧基、喹啉氧基、吡啶氧基或类似物。该化合物对结核分枝杆菌、多药耐药结核分枝杆菌和非典型耐酸细菌具有出色的杀菌作用。
  • 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis
    申请人:Tsubouchi Hidetsugu
    公开号:US20080119478A1
    公开(公告)日:2008-05-22
    The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: (1) in the above formula (1), R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R1 and —(CH2) n R2 may form a spiro ring represented by the formula (30) below, together with the adjacent carbon atom (in the formula below, RRR represents a piperidyl group which may have substituents on the piperidine ring), (30) and R2 represents a benzothiazolyloxy group, quinolyloxy group, pyridyloxy group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis , multi-drug-resistant Mycobacterium tuberculosis , and atypical acid-fast bacteria.
    本发明提供了一种由下述通式(1)表示的2,3-二氢-6-硝基咪唑[2,1-b]噁唑化合物: 在上述式(1)中,R1代表氢原子或C1-C6烷基,n代表0到6的整数,R1和—(CH2)nR2可以与相邻的碳原子形成如下式(30)所示的螺环,其中,在下式中,RRR代表可能在哌啶环上具有取代基的哌啶基: (30)且R2代表苯并噻唑氧基、喹啉氧基、吡啶氧基或类似基团。该化合物对结核分枝杆菌、多重耐药结核分枝杆菌和非典型酸杆菌具有优异的杀菌作用。
查看更多